Drug intelligence / Profile preview

jian pi xiao ji fang

Development stage
Unknown
Lead developer
Longhua Hospital Shanghai University of Traditional Chinese Medicine
Administration
Oral
01

Overview

Jian Pi Xiao Ji Fang (JPXJF) is a Traditional Chinese Medicine (TCM) herbal formula primarily developed and studied for the treatment of hepatocellular carcinoma (HCC). The formula is based on the TCM principle of "strengthening the spleen and resolving accumulation" (Jianpi Xiaoji). It typically consists of a complex mixture of herbs, including *Astragalus membranaceus* (Huangqi), *Atractylodes macrocephala* (Baizhu), *Curcuma zedoaria* (Ezhu), and *Scutellaria barbata* (Banzhilian). JPXJF is frequently used as an adjuvant therapy to transarterial chemoembolization (TACE) or systemic therapies like sorafenib. Its pharmacological effects include the inhibition of tumor angiogenesis via the downregulation of vascular endothelial growth factor (VEGF), induction of apoptosis through the activation of caspases, and modulation of the PI3K/Akt/mTOR signaling pathway. Clinical studies have indicated that JPXJF can improve survival rates, enhance immune function, and reduce the adverse effects of conventional chemotherapy in patients with advanced liver cancer.

Other names
Jianpi Xiaoji DecoctionJianpi Xiaoji Formula健脾消积方
02

Targets

AKT (RAC-alpha serine/threonine-protein kinase)PI3K (Phosphoinositide-3-kinase regulatory subunit 6)VEGFA (Vascular endothelial growth factor A)CASP3 (Caspase-3)

Beyond the preview

Go deeper on jian pi xiao ji fang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on jian pi xiao ji fang.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call